Role of a novel prostaglandin transporter OAT-PG in sodium transport regulation mechanism
新型前列腺素转运蛋白OAT-PG在钠转运调节机制中的作用
基本信息
- 批准号:18590900
- 负责人:
- 金额:$ 1.73万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2006
- 资助国家:日本
- 起止时间:2006 至 2007
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
In the kidney, prostaglandins (PGs), especially prostaglandin E_2(PGE_2), have important roles in renal hemodynamics, renin release, tubular sodium and water reabsorption. Because PGs are charged organic anions at physiological pH, they poorly penetrate biological membranes. Accordingly, PG transport is a carrie瀕ediated process. So far only prostaglandin transporter (PGT) from OATP (SLC0/SLC21) family is known as a transporter specific to PGs. Recently, we isolated a cDNA encoding a novel prostaglandin-specific transporter from mouse kidney. Because this transporter belongs to organic anion transporter (OAT) family (SLC22) structurally distinct from PGT, we named this prostaglandin-specific organic anion transporter (OAT-PG). OAT-PG specifically mediated a transport of PGs such as PGE_2 and PGF_<2a>. It was speculated that OAT-PG plays an important role in renal handling of PGE_2 and contributes to physiological functions involving in PGE_2 metabolism. Particularly, through the interac … More tion with COX-2 and EP4 receptor, PGE_2 may function as a signaling molecule that regulates the sodium transport at the distal segments of nephron.This study was performed to examine the possibility that OAT-PG constitute the renal apical prostaglandin signaling mechanism. First, we investigate the driving force of OAT-PG-mediated PGs transport because in in vitro PG transport via OAT-PG seems bidirectional By using trans-stimulatory experiments, we identified that inorganic sulfate ion may be a counter ion for OATPG-mediated PGs transport. Next, to confirm that the components of renal apical PG signaling such as OATPG, COX-2and EP4 are tethered by some kind of scaffolding protein (s), we perfomed the yeast two-hybrid screening of kidney cDNA library using OATPG C-terminal sequence as bait. From this screening, we succeeded to identify that multivalent PDZ-domain protein CIPP (Channel-Interacting PDZ protein) is the binding partner of OAT-PG. These results will contribute to the clarification of renal apical PG signaling mechanism surrounding OAT-PG. Less
在肾脏中,前列腺素(PGs)尤其是前列腺素E_2(PGE_2)在肾血流动力学、肾素释放、肾小管钠和水重吸收等方面发挥着重要作用。由于PG在生理pH下是带电的有机阴离子,它们很难穿透生物膜。因此,PG运输是一个由Carrie瀕编辑的过程。到目前为止,只有OATP(SLC0/SLC21)家族的前列腺素转运体(PGT)被认为是PGs的专一性转运体。最近,我们从小鼠肾脏中克隆了一种新的前列腺素转运蛋白的编码基因。由于该转运体属于有机阴离子转运体(OAT)家族(SLC22),在结构上不同于PGT,因此我们将其命名为前列腺素特异性有机阴离子转运体(OAT-PG)。OAT-PG特异性地介导了PGE_2和PGF_2a>;等PGs的转运。推测OAT-PG在PGE_2的肾脏处理中起重要作用,并参与参与PGE_2代谢的生理功能。特别是通过Interac…在COX-2和EP4受体的作用下,PGE_2可能是调节肾远端钠转运的信号分子。本研究旨在探讨OAT-PG构成肾尖前列腺素信号转导机制的可能性。首先,我们研究了OAT-PG介导的PGs转运的驱动力,因为在体外通过OAT-PG的PG转运似乎是双向的。通过反式刺激实验,我们发现无机硫酸盐离子可能是OATPG介导的PGs转运的反离子。接下来,为了证实肾尖PG信号的组成成分OATPG、COX-2和EP4是否被某种支架蛋白(S)所束缚,我们以OATPG的C端序列为诱饵,进行了肾脏cDNA库的酵母双杂交筛选。通过这次筛选,我们成功地鉴定了多价PDZ结构域蛋白CIPP(Channel-Interaction PDZ Protein)是OAT-PG的结合伙伴。这些结果有助于阐明围绕OAT-PG的肾尖PG信号转导机制。较少
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Regulation of steroid hormone biosynthesis enzymes and organic anion transporters by forskolin and DHEA-S treatment in adrenocortical cells
- DOI:10.1152/ajpendo.00653.2005
- 发表时间:2006-12-01
- 期刊:
- 影响因子:5.1
- 作者:Asif, Abdul R.;Ljubojevic, Marija;Hagos, Yohannes
- 通讯作者:Hagos, Yohannes
Transcellular transport of organic ions: Basic and clinical importance of transporters
有机离子的跨细胞转运:转运蛋白的基础和临床重要性
- DOI:
- 发表时间:2007
- 期刊:
- 影响因子:0
- 作者:Arai;H.;Mune;M.;Yoshida;K.;et. al.;田邊 克幸;Naohiko Anzai
- 通讯作者:Naohiko Anzai
Plasma urate level is directly regulated by a voltage-driven urate efflux transporter URATv1 (SLC2A9) in humans
- DOI:10.1074/jbc.c800156200
- 发表时间:2008-10-03
- 期刊:
- 影响因子:4.8
- 作者:Anzai, Naohiko;Ichida, Kimiyoshi;Sakurai, Hiroyuki
- 通讯作者:Sakurai, Hiroyuki
Novel liver‐specific organic anion transporter OAT7 that operates the exchange of sulfate conjugates for short chain fatty acid butyrate
- DOI:10.1002/hep.21596
- 发表时间:2007-04
- 期刊:
- 影响因子:13.5
- 作者:H. Shin;N. Anzai;A. Enomoto;Xin He;Do Kyung Kim;H. Endou;Y. Kanai
- 通讯作者:H. Shin;N. Anzai;A. Enomoto;Xin He;Do Kyung Kim;H. Endou;Y. Kanai
有機イオンの細胞膜輸送 : トランスポーターの基礎と臨床
有机离子的细胞膜转运:转运蛋白的基本和临床方面
- DOI:
- 发表时间:2007
- 期刊:
- 影响因子:0
- 作者:新井 英之;宗正 敏;吉田 康一;二木 鋭雄;富永 潤史;菅 多恵子;井上 健一郎;宮崎 正信;原田 孝司;河野 茂;田邊 克幸;安西 尚彦
- 通讯作者:安西 尚彦
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANZAI Naohiko其他文献
ANZAI Naohiko的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANZAI Naohiko', 18)}}的其他基金
New drug development targeting novel renal tubular rate transporter MCT9 based on the structure-activity relationship
基于构效关系的新型肾小管速率转运蛋白MCT9的新药开发
- 批准号:
18K08200 - 财政年份:2018
- 资助金额:
$ 1.73万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Novel regulatory mechanism of renaltubular transporter function by SUMOylation-deSUMOylation
SUMO化-去SUMO化调节肾小管转运蛋白功能的新机制
- 批准号:
23659447 - 财政年份:2011
- 资助金额:
$ 1.73万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
New drug development for hyperuricemia targeting novel urate efflux transporter URATv1
针对新型尿酸外排转运蛋白 URATv1 的高尿酸血症新药开发
- 批准号:
21390073 - 财政年份:2009
- 资助金额:
$ 1.73万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Regulatory mechanism of urate transport function by urate transporter binding protein PDZK1
尿酸盐转运蛋白PDZK1对尿酸盐转运功能的调控机制
- 批准号:
15590233 - 财政年份:2003
- 资助金额:
$ 1.73万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似国自然基金
Kidney injury molecular(KIM-1)介导肾小管上皮细胞自噬在糖尿病肾病肾间质纤维化中的作用
- 批准号:81300605
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
相似海外基金
患者由来kidney-on-a-chipを用いた慢性腎臓病の病態解明と創薬
使用源自患者的肾脏芯片阐明慢性肾脏疾病的病理学和药物发现
- 批准号:
24K03249 - 财政年份:2024
- 资助金额:
$ 1.73万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
The gut-kidney-heart axis as a driver of cardiovascular disease progression
肠-肾-心轴是心血管疾病进展的驱动因素
- 批准号:
MR/Y010051/1 - 财政年份:2024
- 资助金额:
$ 1.73万 - 项目类别:
Fellowship
Navigate homogenesis nephrogenesis in kidney organoid by microfabrication of 3D extracellular matrix.
通过 3D 细胞外基质的微加工来引导肾脏类器官中的同质肾发生。
- 批准号:
24K21098 - 财政年份:2024
- 资助金额:
$ 1.73万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
KitNewCare - Developing a framework/model to environmentally sustainable and climate neutral health and care systems using the Kidney care pathway
KitNewCare - 使用肾脏护理途径开发环境可持续和气候中性的健康和护理系统框架/模型
- 批准号:
10110449 - 财政年份:2024
- 资助金额:
$ 1.73万 - 项目类别:
EU-Funded
Indication selection, patient stratification, and IND preparation for STX-002: the first-in-class LRG1 inhibitor for treatment of chronic kidney disease and immunotherapy-resistant tumours.
STX-002的适应症选择、患者分层和IND准备:用于治疗慢性肾病和免疫治疗耐药肿瘤的一流LRG1抑制剂。
- 批准号:
10092585 - 财政年份:2024
- 资助金额:
$ 1.73万 - 项目类别:
Collaborative R&D
Understanding the link between kidney health and pregnancy outcomes
了解肾脏健康与妊娠结局之间的联系
- 批准号:
MR/Y011139/1 - 财政年份:2024
- 资助金额:
$ 1.73万 - 项目类别:
Fellowship
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 1.73万 - 项目类别:
Standard Grant
本邦におけるKidney Exchange Program構築のための多施設共同研究
多中心联合研究在日本建立肾脏交换项目
- 批准号:
24K11796 - 财政年份:2024
- 资助金额:
$ 1.73万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Understanding BK virus in kidney transplantation
了解肾移植中的 BK 病毒
- 批准号:
MR/X030997/1 - 财政年份:2024
- 资助金额:
$ 1.73万 - 项目类别:
Research Grant
Expression regulation and morphological and function analysis of Piezo1 and Piezo2 in the kidney using genetically engineered mice
基因工程小鼠肾脏中 Piezo1 和 Piezo2 的表达调控及形态和功能分析
- 批准号:
23K07704 - 财政年份:2023
- 资助金额:
$ 1.73万 - 项目类别:
Grant-in-Aid for Scientific Research (C)